| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cidara Therapeutics Inc (NASDAQ: CDTX)
CDTX Technical Analysis
5
| As on 14th Nov 2025 CDTX STOCK Price closed @ 217.71 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 16.66 & Strong Buy for SHORT-TERM with Stoploss of 12.23 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CDTXSTOCK Price
| Open | 217.20 | Change | Price | % |
| High | 218.85 | 1 Day | 111.72 | 105.41 |
| Low | 216.80 | 1 Week | 120.07 | 122.97 |
| Close | 217.71 | 1 Month | 115.72 | 113.46 |
| Volume | 17287439 | 1 Year | 205.69 | 1711.23 |
| 52 Week High 116.15 | 52 Week Low 10.17 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 190.17 | 1.77% |
| OPEN | 8.12 | -5.14% |
| ONDS | 7.20 | 9.76% |
| BYND | 1.08 | 6.93% |
| LMDX | 0.02 | 0.00% |
| TSLA | 404.35 | 0.59% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CDTX Daily Charts |
CDTX Intraday Charts |
Whats New @ Bazaartrend |
CDTX Free Analysis |
|
|
CDTX Important Levels Intraday
| RESISTANCE | 221.66 |
| RESISTANCE | 220.39 |
| RESISTANCE | 219.61 |
| RESISTANCE | 218.83 |
| SUPPORT | 216.59 |
| SUPPORT | 215.81 |
| SUPPORT | 215.03 |
| SUPPORT | 213.76 |
CDTX Forecast November 2025
| 4th UP Forecast | 225.5 |
| 3rd UP Forecast | 223 |
| 2nd UP Forecast | 221.46 |
| 1st UP Forecast | 219.91 |
| 1st DOWN Forecast | 215.51 |
| 2nd DOWN Forecast | 213.96 |
| 3rd DOWN Forecast | 212.42 |
| 4th DOWN Forecast | 209.92 |
CDTX Weekly Forecast
| 4th UP Forecast | 221.85 |
| 3rd UP Forecast | 220.52 |
| 2nd UP Forecast | 219.70 |
| 1st UP Forecast | 218.88 |
| 1st DOWN Forecast | 216.54 |
| 2nd DOWN Forecast | 215.72 |
| 3rd DOWN Forecast | 214.90 |
| 4th DOWN Forecast | 213.57 |
CDTX Forecast2025
| 4th UP Forecast | 619.89 |
| 3rd UP Forecast | 490.91 |
| 2nd UP Forecast | 411.18 |
| 1st UP Forecast | 331.46 |
| 1st DOWN Forecast | 103.96 |
| 2nd DOWN Forecast | 24.24 |
| 3rd DOWN Forecast | -55.49 |
| 4th DOWN Forecast | -184.47 |
Cidara Therapeutics Inc ( NASDAQ USA Symbol : CDTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CDTX Business Profile
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel long-acting anti-infectives for the treatment and prevention of diseases in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop antiviral conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Address: 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service